<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0004805"><a href="http://purl.obolibrary.org/obo/MONDO_0004805">MONDO:0004805</a></h3>
<p><strong>Label:</strong> leukocyte disease</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019438">MONDO:0019438</a> (AL amyloidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019315">MONDO:0019315</a> (diffuse cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019316">MONDO:0019316</a> (Maculopapular cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0009693">MONDO:0009693</a> (multiple myeloma), <a href="http://purl.obolibrary.org/obo/MONDO_0016586">MONDO:0016586</a> (systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0018542">MONDO:0018542</a> (severe congenital neutropenia), <a href="http://purl.obolibrary.org/obo/MONDO_0019023">MONDO:0019023</a> (cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0004948">MONDO:0004948</a> (chronic lymphocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020331">MONDO:0020331</a> (indolent systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0008742">MONDO:0008742</a> (autosomal dominant severe congenital neutropenia), <a href="http://purl.obolibrary.org/obo/MONDO_0020333">MONDO:0020333</a> (aggressive systemic mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0020334">MONDO:0020334</a> (mast cell leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0007926">MONDO:0007926</a> (Waldenstrom macroglobulinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005615">MONDO:0005615</a> (plasmacytoma), <a href="http://purl.obolibrary.org/obo/MONDO_0000432">MONDO:0000432</a> (lymphoplasmacytic lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007950">MONDO:0007950</a> (mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018906">MONDO:0018906</a> (follicular lymphoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_486">Orphanet:486</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33226">Orphanet:33226</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86855">Orphanet:86855</a>, <a href="http://purl.obolibrary.org/obo/OMIM_153600">OMIM:153600</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85443">Orphanet:85443</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151400">OMIM:151400</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615285">OMIM:615285</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2467">Orphanet:2467</a>, <a href="http://www.orpha.net/ORDO/Orphanet_67038">Orphanet:67038</a>, <a href="http://purl.obolibrary.org/obo/OMIM_154800">OMIM:154800</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613024">OMIM:613024</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610430">OMIM:610430</a>, <a href="http://www.orpha.net/ORDO/Orphanet_66646">Orphanet:66646</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612558">OMIM:612558</a>, <a href="http://www.orpha.net/ORDO/Orphanet_42738">Orphanet:42738</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613107">OMIM:613107</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612557">OMIM:612557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609630">OMIM:609630</a>, <a href="http://purl.obolibrary.org/obo/OMIM_202700">OMIM:202700</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254500">OMIM:254500</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612559">OMIM:612559</a>, <a href="http://purl.obolibrary.org/obo/OMIM_109543">OMIM:109543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98850">Orphanet:98850</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98851">Orphanet:98851</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610738">OMIM:610738</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79456">Orphanet:79456</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79457">Orphanet:79457</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300299">OMIM:300299</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98292">Orphanet:98292</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86788">Orphanet:86788</a>, <a href="http://www.orpha.net/ORDO/Orphanet_29073">Orphanet:29073</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616022">OMIM:616022</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612541">OMIM:612541</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98848">Orphanet:98848</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314701">Orphanet:314701</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://purl.obolibrary.org/obo/OMIM_257100">OMIM:257100</a>, <a href="http://www.orpha.net/ORDO/Orphanet_545">Orphanet:545</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 55.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 48.83%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010974">HP:0010974</a> (Abnormality of myeloid leukocytes) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 47.32%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 46.78%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0010974">HP:0010974</a> (Abnormality of myeloid leukocytes) 46.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 46.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 44.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 42.66%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) 41.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 40.26%</li>
<li>Thing 40.23%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 40.23%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument) and <a href="http://purl.obolibrary.org/obo/HP_0010974">HP:0010974</a> (Abnormality of myeloid leukocytes) 37.55%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) and <a href="http://purl.obolibrary.org/obo/HP_0010974">HP:0010974</a> (Abnormality of myeloid leukocytes) 37.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001911">HP:0001911</a> (Abnormality of granulocytes) and <a href="http://purl.obolibrary.org/obo/HP_0011893">HP:0011893</a> (Abnormal leukocyte count) 36.88%</li>
</ul>
</body>
</html>
